Literature DB >> 1639010

Endothelin-1 actions on resorption, collagen and noncollagen protein synthesis, and phosphatidylinositol turnover in bone organ cultures.

A Tatrai1, S Foster, P Lakatos, G Shankar, P H Stern.   

Abstract

The effects of endothelin-1 (ET) on several tissues are mediated by prostaglandins. In this study, we investigated the actions of ET on bone and determined whether they are mediated through prostaglandin-dependent pathways. Bone resorption, collagen, and non-collagen protein synthesis and inositol phosphate (IP) production were studied in neonatal mouse calvaria and fetal rat limb bone cultures. The effects of ET in the calvaria model were examined in the presence or absence of the cyclooxygenase inhibitor indomethacin (INDO). Bone resorption was stimulated by ET in the neonatal mouse calvaria, and this effect was inhibited by INDO. 45Ca release in the fetal rat limb bones was not affected by ET. ET stimulated collagen and noncollagen protein synthesis significantly in the calvaria model in the presence but not in the absence of INDO, suggesting that the anabolic effects of ET were masked by endogenous prostaglandin production. ET increased phosphatidylinositol turnover in both bone organ cultures. Although the addition of INDO reduced IP production slightly in the mouse calvaria, it was still significantly stimulated by ET. Our results demonstrate that ET has marked effects on bone tissue in vitro. Effects on resorption appear to be prostaglandin dependent, whereas the anabolic effects were not prostaglandin mediated. The stimulatory effects of ET on protein synthesis could be mediated through the IP signaling pathway. Since ET stimulates both bone resorption and anabolism, this peptide may have a role in the coupling of bone remodeling.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639010     DOI: 10.1210/endo.131.2.1639010

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  Endothelin concentrations are elevated in plasma of patients with primary and secondary hyperparathyroidism.

Authors:  P Lakatos; A Tátrai; J Földes; C Horváth; J Makó; P H Stern
Journal:  Calcif Tissue Int       Date:  1996-01       Impact factor: 4.333

2.  Osteoclast responses to lipopolysaccharide, parathyroid hormone and bisphosphonates in neonatal murine calvaria analyzed by laser scanning confocal microscopy.

Authors:  Keiko Suzuki; Sadaaki Takeyama; Takashi Kikuchi; Shoji Yamada; Jaro Sodek; Hisashi Shinoda
Journal:  J Histochem Cytochem       Date:  2005-08-08       Impact factor: 2.479

3.  Osteopenia and endothelin-1-mediated vasconstrictor tone in postmenopausal women.

Authors:  Michael L Mestek; Brian R Weil; Jared J Greiner; Christian M Westby; Christopher A DeSouza; Brian L Stauffer
Journal:  Bone       Date:  2010-06-01       Impact factor: 4.398

4.  What is the role of bosentan in healing of femur fractures in a rat model?

Authors:  Ali Aydin; Zekai Halici; Erol Akpinar; A Murat Aksakal; Murat Saritemur; Muhammed Yayla; C Semih Kunak; Elif Cadirci; H Tarik Atmaca; S Sena Karcioglu
Journal:  J Bone Miner Metab       Date:  2014-10-09       Impact factor: 2.626

5.  Therapeutic values of chick early amniotic fluid (ceAF) that facilitates wound healing via potentiating a SASP-mediated transient senescence.

Authors:  Mashaal Ahmad; Yandi Sun; Xueyao Jia; Jingjia Li; Lihong Zhang; Ze Yang; Yindan Lin; Xueyun Zhang; Zara Ahmad Khan; Jin Qian; Yan Luo
Journal:  Genes Dis       Date:  2021-03-22

6.  Cardiac myofibroblasts isolated from the site of myocardial infarction express endothelin de novo.

Authors:  Laxmansa C Katwa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-05-08       Impact factor: 4.733

Review 7.  Endothelin-1 as a target for therapeutic intervention in prostate cancer.

Authors:  E Scott Kopetz; Joel B Nelson; Michael A Carducci
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850

8.  Comparison of plasma endothelin levels between osteoporotic, osteopenic and normal subjects.

Authors:  Hasan Hilmi Muratli; Levent Celebi; Onur Hapa; Ali Biçimoğlu
Journal:  BMC Musculoskelet Disord       Date:  2005-09-20       Impact factor: 2.362

9.  Bosentan, a drug used in the treatment of pulmonary hypertension, can prevent development of osteoporosis.

Authors:  Duygu Köse; Ahmet Köse; Zekai Halıcı; Elif Çadırcı; Taha Tavacı; Muhammed Ali Gürbüz; Adem Maman
Journal:  Iran J Basic Med Sci       Date:  2021-07       Impact factor: 2.699

10.  Glucocorticoids regulate the expression of the human osteoblastic endothelin A receptor gene.

Authors:  I Börcsök; H U Schairer; U Sommer; G K Wakley; U Schneider; F Geiger; F U Niethard; R Ziegler; C H Kasperk
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.